Uptick in respiratory illnesses across the U.S.
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Watch CBS News
Several states are reporting high levels of influenza this holiday season. While nationwide, less than half of children and adults have gotten the flu vaccine. Lilia Luciano has more.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Congressional Democrats want to pump $50 billion into the training and hiring of more public health nurses ― a cash infusion they say would improve both working conditions for nurses and health outcomes for underserved communities. Lawmakers planned to introduce bills in both the House and Senate on Wednesday to establish a grant program for…
Experts are not too concerned about a new variant of Covid but say monitoring should continue.
Health 25 July 2023, 6:19 pm 1 minute Reuters exclusively reported that India’s pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, a government-backed trade body told Reuters, despite deaths linked to Indian-made cough syrups. Market Impact…
How to identify severe flu symptoms in children – CBS News Watch CBS News Flu cases are surging nationwide and 27 children are among those who have died this flu season. One hospital shares ways to be on the lookout for respiratory issues. Janet Shamlian reports. Be the first to know Get browser notifications for…
It’s accurate to assume that germs are lurking everywhere in your home, but your mattress is one particular place that harbors untold microorganisms that many of us prefer not to think about. In fact, mattresses are more disgusting than you might ever have imagined, according to Manal Mohammed, a medical microbiologist and senior lecturer at London’s University…
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….